Genocea Biosciences Management
Management criteria checks 2/4
We currently do not have sufficient information about the CEO.
Key information
Chip Clark
Chief executive officer
US$3.8m
Total compensation
| CEO salary percentage | 15.2% |
| CEO tenure | 12.3yrs |
| CEO ownership | n/a |
| Management average tenure | 7.3yrs |
| Board average tenure | 8.7yrs |
Recent management updates
Recent updates
Here's Why Shareholders May Want To Be Cautious With Increasing Genocea Biosciences, Inc.'s (NASDAQ:GNCA) CEO Pay Packet
Jun 17
What Type Of Returns Would Genocea Biosciences'(NASDAQ:GNCA) Shareholders Have Earned If They Purchased Their SharesFive Years Ago?
Feb 18How Much Of Genocea Biosciences, Inc. (NASDAQ:GNCA) Do Institutions Own?
Jan 14
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Mar 31 2022 | n/a | n/a | -US$37m |
| Dec 31 2021 | US$4m | US$571k | -US$33m |
| Sep 30 2021 | n/a | n/a | -US$35m |
| Jun 30 2021 | n/a | n/a | -US$36m |
| Mar 31 2021 | n/a | n/a | -US$43m |
| Dec 31 2020 | US$1m | US$551k | -US$44m |
| Sep 30 2020 | n/a | n/a | -US$38m |
| Jun 30 2020 | n/a | n/a | -US$41m |
| Mar 31 2020 | n/a | n/a | -US$36m |
| Dec 31 2019 | US$1m | US$533k | -US$39m |
| Sep 30 2019 | n/a | n/a | -US$29m |
| Jun 30 2019 | n/a | n/a | -US$30m |
| Mar 31 2019 | n/a | n/a | -US$27m |
| Dec 31 2018 | US$1m | US$515k | -US$28m |
| Sep 30 2018 | n/a | n/a | -US$39m |
| Jun 30 2018 | n/a | n/a | -US$48m |
| Mar 31 2018 | n/a | n/a | -US$59m |
| Dec 31 2017 | US$2m | US$493k | -US$57m |
| Sep 30 2017 | n/a | n/a | -US$62m |
| Jun 30 2017 | n/a | n/a | -US$58m |
| Mar 31 2017 | n/a | n/a | -US$54m |
| Dec 31 2016 | US$1m | US$455k | -US$50m |
Compensation vs Market: Chip's total compensation ($USD3.75M) is above average for companies of similar size in the US market ($USD740.57K).
Compensation vs Earnings: Chip's compensation has increased whilst the company is unprofitable.
CEO
Chip Clark (53 yo)
12.3yrs
Tenure
US$3,750,857
Compensation
Mr. William D. Clark, M.B.A., also known as Chip, has been an Independent Director at iBio, Inc. since August 26, 2021 and serves as its Chairman since November 2022. He has been the Director, Chief Execut...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 12.3yrs | US$3.75m | no data | |
| Chief Scientific Officer | 7.3yrs | US$1.27m | no data | |
| CFO & Secretary | 4.2yrs | no data | no data |
7.3yrs
Average Tenure
50yo
Average Age
Experienced Management: GNCA.Q's management team is seasoned and experienced (7.3 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 12.3yrs | US$3.75m | no data | |
| Independent Chairman of the Board | 8.7yrs | US$120.98k | no data | |
| Independent Director | 8.3yrs | US$78.48k | no data | |
| Independent Director | 10.2yrs | US$75.88k | no data | |
| Independent Chairman of Scientific Advisory Board & Director | 16.3yrs | US$66.98k | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Independent Director | 1.7yrs | US$61.50k | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Independent Director | 1.2yrs | no data | no data |
8.7yrs
Average Tenure
53.5yo
Average Age
Experienced Board: GNCA.Q's board of directors are considered experienced (8.7 years average tenure).